George Washington University School of Medicine, Washington, DC. RATIONALE: The relationship between the site of hymenoptera sting and the severity of anaphylaxis after the sting has not been reported in Europe. METHODS: A retrospective study was conducted of medical records from 429 patients including 231 women ( 54.6%) and 198 men, mean age 40.0 6 6.8 years, treated for hymenoptera venom stings among 2674 allergic patients seen from 1992 to 2016 in Silesia, Poland. Medical care provided was assessed. Patients were classified based on the insect type and site of a sting: head and neck, back and torso, upper limb, and lower limb. RESULTS: The majority of patients experienced a severe anaphylactic reaction ( 66%). Anaphylaxis was caused mostly by vespids -235 followed by honey bee-194 . Most severe anaphylaxis developed after a sting in head and neck region ( 59% honey bee and 53% wasp), followed by sting in the upper limbs with less severe symptoms ( 44% honey bee, 36% wasp). Epinephrine was used only in 13 % of anaphylaxis patients overall, but during the last five years (2010-15) epinephrine was administered in 36% patient, a statistically significant change (p<0.05). 44 patients who had anaphylaxis were hospitalized (12.6%). CONCLUSIONS: The site of a Hymenoptera sting influences the progress and intensity of the anaphylactic reactions. Head and neck stings are particularly dangerous, whereas stings of the lower limbs induced less severe symptoms. Use of epinephrine as observed the therapeutic interventions for venom anaphylaxis needs to be further enhanced. METHODS: A case series of 4 patients evaluated for a combination of immediate symptoms including urticaria, angioedema, bronchospasm, pre-syncope and gastrointestinal distress. During the evaluation each patient noted ingestion of a dietary protein supplement in close proximity to the onset of symptoms. RESULTS: A total of 4 patients were skin prick tested to the exact protein product which potentially elicitedtheir reaction. This was done by the ''prick-prick'' method once the protein product had been made into solution with saline. Three patients demonstrated a wheal >3mm of saline control to the dietary protein product. All 3 patients with positive skin prick testing reacted to a whey protein product,but 2 patients continue to tolerate traditional cow's milk products (i.e.milk with cereal). There was one patient who did not show sensitization to the protein product tested. Each dietary product was tested in duplicate by ''prick-prick'' on control subjects without demonstrating dermal reactivity. CONCLUSIONS: Ingestion of concentrated dietary protein supplementation products may result in allergic reactions. These reactions appear to be unique to the whey protein supplement rather than a global cow's milk allergy. There may be factors associated with supplement preparation and processing which result in more immunogenic antigens in these highly concentrated protein products. We suggest questioning patients about the use of protein supplements when presenting with symptoms suggestive of an IgE mediated food allergy. 2 University Medical Center Hamburg-Eppendorf, Hamburg, Germany. RATIONALE: In allergic emergencies, epinephrine will be injected through worn clothing. Infections even with highly pathogenic bacteria have sporadically been observed after use of epinephrine auto-injectors (EAI). Adherence of sufficient bacteria to needles is a critical determinant to develop an infection. Here, we quantified reference bacterial species on EAI needles. METHODS: Staphylococcus aureus (BA976), Escherichia coli (ATCC25922), Staphylococcus epidermidis (1585), Bacillus subtilis (ATCC23857) spores were grown, harvested and suspended in concentrations of 10 3 , 10 6 , and 10 8 CFU/mL using standard microbiologically techniques. Sterile steel needles were exposed for 3, 5, 10, and 60 s. Adherent bacteria were removed and plated for quantification. To determine the influence of storage on adherent cell replication, needles were placed in a sterile dry tube for 5, 15, 60 min, and 24 h. RESULTS: After 60 s, suspensions of 10 3 CFU/mL showed no adherence to needles. Suspensions of 10 6 and 10 8 CFU/mL showed adherence of 13 -40 cells and 1453 -9400 cells respectively. After 5 min storage low numbers of adherent bacteria could be recovered from the needle (430 CFU/mL [B. subtilis] and 3800 CFU/mL [S. aureus]). Storage of needles over time resulted in a decline of viable adherent bacteria for S. aureus and E. coli. The amount of adherent B. subtilis remained stable. CONCLUSIONS: Extrapolating the results to the conditions of human skin, carrying roughly 10 2 CFU/cm 2 , adherence of significant numbers of bacteria and their replication above the infective threshold of 100 bacteria per needle, is most unlikely and therefore microbiologically save.
